In a magnet system: —a superconducting main field magnet (7) generates a magnetic field in a first sample volume (16), —a superconducting additional field magnet (22) generates another field in a second sample volume (24), —a cryostat (2) has a cooled main coil container (6), an evacuated RT (room temperature) covering (4), and an RT bore (14) which extends through the main and the additional field magnets, and —a cooled additional coil container (21) in a vacuum. The RT covering has a flange connection (17) with an opening (19) through which the RT bore extends, a front end of the additional coil container protrudes through the opening into the RT covering such that the additional field magnet also protrudes through the opening into the RT covering, and a closure structure (20) seals the RT covering between the flange connection and the RT bore.

The invention relates to a sample cell for performing DNP-NMR measurements, for interchangeable use in an EPR microwave resonator, with the sample cell comprising a flat sample cavity for holding a liquid sample to be measured, wherein the flat sample cavity extends with a maximum length L and a maximum width W in a sample cavity plane, and extends with a maximum height H perpendicular to the sample cavity plane, with H≤ 1/15*L and H≤ 1/15*W, and an NMR coil wound around the flat sample cavity for generating an RF magnetic field B.sub.2, wherein a coil axis of the NMR coil about which the NMR coil is wound is oriented perpendicular to the sample cavity plane. The invention provides a sample cell which is easy to handle and improves the quality and the reproducibility of DNP-NMR measurements.

A system can include: a superconducting or permanent magnet; a high field portion corresponding to the superconducting or permanent magnet, wherein the high field has a range of 0.1-20 T; a low field portion positioned outside of the superconducting or permanent magnet, wherein the low field has a range of 0.01 nT-100 mT; a shuttling mechanism configured to deliver a sample between the low field portion and the high field portion; and a polarization sub-assembly configured to hyperpolarize the sample while the sample is within the low field portion. A device can be configured to cause nuclear spin hyperpolarization in diamond particles such that the hyperpolarization is transferable to at least one of an external liquid or an external solid. A process of hyperpolarizing substances can include applying optical illumination to the substance, irradiating the substance with a series of microwave signals as one of either a single signal or as a frequency comb to hyperpolarize the nuclei in the substance, and relaying polarization to nuclear spins of one of a surrounding solid or fluid.

Disclosed are methods for performing dynamic nuclear polarization using the polarizing agents described herein. In general, the methods involve (a) providing a frozen sample in a magnetic field, wherein the frozen sample includes a polarizing agent described herein and an analyte with at least one spin half nucleus; (b) polarizing the at least one spin half nucleus of the analyte by irradiating the frozen sample with radiation having a frequency that excites electron spin transitions in the polarizing agent; (c) optionally melting the sample to produce a molten sample; and (d) detecting nuclear spin transitions in the at least one spin half nucleus of the analyte in the frozen or molten sample. In certain embodiments, the polarizing agents can be peptide-based. In these embodiments, the polarizing agents can be readily prepared by solid-phase peptide synthesis.

Disclosed are methods for performing dynamic nuclear polarization using the polarizing agents described herein. In general, the methods involve (a) providing a frozen sample in a magnetic field, wherein the frozen sample includes a polarizing agent described herein and an analyte with at least one spin half nucleus; (b) polarizing the at least one spin half nucleus of the analyte by irradiating the frozen sample with radiation having a frequency that excites electron spin transitions in the polarizing agent; (c) optionally melting the sample to produce a molten sample; and (d) detecting nuclear spin transitions in the at least one spin half nucleus of the analyte in the frozen or molten sample. In certain embodiments, the polarizing agents can be peptide-based. In these embodiments, the polarizing agents can be readily prepared by solid-phase peptide synthesis.

The present invention relates to novel organic dinitroxide biradical compounds and their use as polarizing agents, in particular, in the techniques of Nuclear Magnetic Resonance (NMR) of solids or liquid samples and medical imaging.

A method for obtaining an index for non-invasively identifying NASH is provided. A NASH determination method comprising a method for acquiring free radical consumption speed information by non-invasively detecting a redox reaction in a liver of a test animal in real time, comprises a step (1) of obtaining free radical concentration data by applying a magnetic resonance method to the liver as a measurement target after administering a probe into a body; a step (2) of obtaining imaging information by processing the obtained free radical concentration data; and a step (3) of obtaining a free radical consumption speed by kinetically measuring the imaging information over time, and comprises a step of determining whether or not the test animal has NASH, based on the free radical consumption speed information obtained through application to the test animal.

A method for obtaining an index for non-invasively identifying NASH is provided. A NASH determination method comprising a method for acquiring free radical consumption speed information by non-invasively detecting a redox reaction in a liver of a test animal in real time, comprises a step (1) of obtaining free radical concentration data by applying a magnetic resonance method to the liver as a measurement target after administering a probe into a body; a step (2) of obtaining imaging information by processing the obtained free radical concentration data; and a step (3) of obtaining a free radical consumption speed by kinetically measuring the imaging information over time, and comprises a step of determining whether or not the test animal has NASH, based on the free radical consumption speed information obtained through application to the test animal.

The present invention relates to novel organic dinitroxide biradical compounds and their use as polarizing agents, in particular, in the techniques of Nuclear Magnetic Resonance (NMR) of solids or liquid samples and medical imaging.

Disclosed are methods for performing dynamic nuclear polarization using the polarizing agents described herein. In general, the methods involve (a) providing a frozen sample in a magnetic field, wherein the frozen sample includes a polarizing agent described herein and an analyte with at least one spin half nucleus; (b) polarizing the at least one spin half nucleus of the analyte by irradiating the frozen sample with radiation having a frequency that excites electron spin transitions in the polarizing agent; (c) optionally melting the sample to produce a molten sample; and (d) detecting nuclear spin transitions in the at least one spin half nucleus of the analyte in the frozen or molten sample. In certain embodiments, the polarizing agents can be peptide-based. In these embodiments, the polarizing agents can be readily prepared by solid-phase peptide synthesis.